The binding of DnaG to DnaB stimulates the activities of DnaB (1) and stabilizes the three-fold conformation of the DnaB NTDs. This suggests that the three-fold symmetric state represents an activated form of DnaB; therefore, it seems doubtful that the DNA translocation mechanism of DnaB involves transitions between six-and three-fold symmetries. Both DnaB and the T7 gp4 proteins require a stable hexamer for NTPase and helicase activity (9, 18). Therefore, the DnaG-mediated stimulation of the activities of DnaB could also result from the increased stability of the hexamer produced by the binding of DnaG, which is consistent with the observation that although the isolated C2 subdomain of the HBD can bind DnaB, both subdomains of the HBD are required for the stimulation of the activities of DnaB (16). Although the presence of DnaG at the replication fork in E. coli has been shown to be distributive (31), the binding of only one molecule of DnaG to DnaB would be sufficient to stabilize the three-fold conformation of DnaB. The closed circular structure of the NTD collar could also contribute to the stimulation of the helicase activity by keeping the two ssDNA strands topologically separated during unwinding. In addition the topological linking of DnaB to the DNA also would ensure that the two molecules could not easily disengage, thus increasing the processivity of the reaction. Kinetic analysis has shown that isolated DnaB is only a moderately processive enzyme, and it is assumed that it gains the processivity needed to replicate the genome from other components of the replication fork (32). A similar processivity role has also been suggested for the unrelated NTD of the papillomavirus E1 helicase (20).
The binding of DnaG to DnaB stimulates the activities of DnaB (1) and stabilizes the three-fold conformation of the DnaB NTDs. This suggests that the three-fold symmetric state represents an activated form of DnaB; therefore, it seems doubtful that the DNA translocation mechanism of DnaB involves transitions between six-and three-fold symmetries. Both DnaB and the T7 gp4 proteins require a stable hexamer for NTPase and helicase activity (9, 18) . Therefore, the DnaG-mediated stimulation of the activities of DnaB could also result from the increased stability of the hexamer produced by the binding of DnaG, which is consistent with the observation that although the isolated C2 subdomain of the HBD can bind DnaB, both subdomains of the HBD are required for the stimulation of the activities of DnaB (16) . Although the presence of DnaG at the replication fork in E. coli has been shown to be distributive (31) , the binding of only one molecule of DnaG to DnaB would be sufficient to stabilize the three-fold conformation of DnaB. The closed circular structure of the NTD collar could also contribute to the stimulation of the helicase activity by keeping the two ssDNA strands topologically separated during unwinding. In addition the topological linking of DnaB to the DNA also would ensure that the two molecules could not easily disengage, thus increasing the processivity of the reaction. Kinetic analysis has shown that isolated DnaB is only a moderately processive enzyme, and it is assumed that it gains the processivity needed to replicate the genome from other components of the replication fork (32) . A similar processivity role has also been suggested for the unrelated NTD of the papillomavirus E1 helicase (20) .
The NTD collar may also provide an additional binding site for ssDNA. The interior surface of the NTD collar exhibits three distinct sites of positive electrostatic potential separated by regions of negative electrostatic potential (Fig. 4A ). These positive sites are consistent with their binding DNA, contain residues that are conserved across DnaB species, and are well positioned for binding the ssDNA as it emanates from the CTD ring (Fig. 4) . Nuclease protection and fluorescence energy transfer studies have also suggested the presence of a second ssDNA binding site at the N terminus of DnaB (33) .
It is now possible to construct a model of the complex between DnaB and DnaG that illuminates how they cooperatively work together and stimulate each other's activities. The N terminus of each HBD is situated adjacent to the central channel of DnaB (Fig. 3) , thereby positioning the N-terminal ZBD and RPD of full-length DnaG directly above the central channel (Fig. 4B) . Thus, the structure of the RPD-ZBD fragment (34) can be positioned relative to the HBD in a manner that orients the primase active site with the proposed N-terminal ssDNA binding site of DnaB and is consistent with the structure of the truncated T7 gp4 helicase-primase heptamer (21) . The structure of the complex between DnaB and HBD, and our modeling of the complex between the full-length proteins, is consistent with the possibility that DnaB stimulates the activity of DnaG by increasing the local concentration of the ssDNA substrate and by ensuring that multiple DnaG subunits are in close proximity to each other (35) (Fig. 4B) (Fig. 1A) (5) . Guanine nucleotide exchange factors (GEFs) facilitate dissociation and exchange of bound nucleotide from Ras. Ras inactivation (by hydrolysis of bound GTP to GDP) can be done at a slow rate by Ras itself through its intrinsic GTPase activity. GTPase-activating proteins (GAPs) increase the rate of GTP hydrolysis. Association of Ras GTP with effector proteins can prevent regulatory enzymes from acting on Ras GTP and can also prevent nucleotide dissociation, thus resulting in a sequestration of Ras GTP (6) . Attempts to understand Ras activation in a systems-level, cellular context must also consider concentrations of proteins that regulate Ras and the rate constants for their reactions.
We developed a mathematical model of the Ras signaling module using established methods for describing signal transduction networks (7), including heterotrimeric GTPbinding protein (G protein) and small GTPase signaling networks (8, 9) . The model accounts for GEF-catalyzed exchange, GAP-catalyzed hydrolysis, intrinsic association and dissociation of nucleotide from Ras, hydrolysis of GTP by Ras, and interaction of Ras GTP with downstream effectors (10) (Fig. 1A) . All rate constants needed to characterize these reactions have been measured previously for wildtype Ras (Ras WT ) ( 12 is replaced by Val (G12V) (11) ] to predict the percentage of total Ras (endogenous and exogenous), or exogenous Ras bound to GTP. Predictions were robust and matched well with experimental data (12) (13) (14) (Fig. 1 , B and C, and table S3). Model predictions for the Ras GAP-deficient state associated with neurofibromatosis also support the ability of the model to make robust, quantitative predictions (SOM text). . (B and C) Experimental data were from published studies (12) (13) (14) . Model predictions are mean ± SD for nine different sets of protein concentration parameters. Presumably, a mutation that disrupts any of the processes that regulate Ras could result in pathological Ras activation. However, only a few modes of deregulation are actually found in disease. We used our model to investigate the sensitivity of Ras activation to changes in each module property and found that Ras activation was largely affected by only four properties ( Fig. 2A) . There was good correlation between these four properties and the known physiological and pathological mechanisms of Ras pathway activation in many cancers (SOM text) (2) . This analysis may help explain why only a limited number of the network properties result in pathological Ras activation when altered, i.e., network behavior is such that a disruption in a module property typically has a minimal effect on Ras activation.
Two of the properties that the model predicts will strongly influence Ras activation are altered in Ras point mutants with in vitro trans-
F28L ), and the k cat for the GAP reaction is strongly decreased for GAPinsensitive mutants (e.g., Ras G12V ). Although both GAP-insensitive and fast-cycling Ras mutants have in vitro transformation potential (15, 16) , only GAP-insensitive Ras mutants are commonly found in cancers (2) . When modeled at concentrations consistent with a spontaneous mutation in vivo, fast-cycling Ras F28L showed approximately half the increase in forming Ras-effector complex of GAP-insensitive Ras G12V (Fig. 2B) . However, when we simulated concentrations consistent with the conditions of in vitro transformation assays, the difference between fast-cycling and GAP-insensitive mutants was reduced, and higher activation levels were achieved for both mutant classes (Fig. 2B) . Results were similar for alternative sets of module protein concentrations ( fig. S1 ).
To . The amount of activated, phosphorylated extracellular signal-regulated kinase (pERK) was used as a readout of Ras activation (2) . Expression of small amounts of Ras F28L caused production of less pERK than did similar amounts of Ras G12V (Fig. 2C and fig. S2 ), in agreement with our model (Fig. 2B) . Both mutants caused large amounts of pERK at higher expression levels (Fig. 2C) . Thus, our computational and experimental results suggest that fast-cycling Ras point mutants may not be found in cancers because they cause a smaller increase in Ras signal amplitude than GAP-insensitive mutants for the concentration range likely to occur with spontaneous mutations.
Biochemical measurements have identified three differences between Ras WT and Ras G12V that might contribute to increased Ras GTP : (i) The rate of GTP hydrolysis for Ras G12V seems unaffected by the addition of GAP (GAP insensitivity) (17); (ii) the intrinsic GTPase activity of Ras G12V is approximately one order of magnitude slower than that of Ras WT (reduced intrinsic GTPase activity) (18) ; and (iii) the affinity of Ras G12V for its downstream effector Raf is approximately doubled (increased effector affinity) (19) . GAP insensitivity has been proposed as the primary cause of increased Ras activation (1). However, this hypothesis has not been testable experimentally because Ras G12V exhibits all of these altered biochemical properties simultaneously.
In our model, GAP insensitivity alone increased the percentage of total Ras existing as Ras GTP to about half that predicted when all mutant properties were included (Fig. 3A  and table S4 ). In contrast, reduced intrinsic GTPase activity and increased effector affinity individually had minimal predicted effect on Ras activation ( Fig. 3A; table S4 ). Reduced intrinsic GTPase activity did cause a predicted further increase when combined with GAP insensitivity, and increased effector affinity also caused a small increase when combined with GAP insensitivity (Fig.  3A) . Essentially similar results were obtained when parameters for Ras G12D were used, which suggests that these results are applicable to other GAP-insensitive Ras point mutants (table S5) .
The combination of GAP insensitivity, reduced GTPase activity, and increased effector affinity did not account for all of the increased Ras activation. Although Ras G12V is GAPinsensitive, it associates with GAP proteins (20) , and could competitively inhibit Ras GAP activity on Ras WT . In our model, formation of Ras GTP was increased when competitive inhi- To determine the fraction of a given isoform bound to GTP, immunoblotting was done using isoform-specific antibodies or a pan-Ras antibody. The signals for Ras GTP in the different cells lines were normalized against total cellular Ras in the same cell line. Results reflect two to five independent experiments, and the differences were significant (P < 0.05, Student's t test).
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bition of Ras GAP was combined with GAP insensitivity (Fig. 3A) . This increase did not result from changes in the fraction of Ras G12V that was GTP-bound (~85% in both cases), rather it was due to an increase in the GTPbound fraction of Ras WT (from 1 to 15%) (table  S4) . Results were similar when alternative sets of module protein concentrations were modeled ( fig. S3 ). This analysis has been done with the assumption that 50% of total cellular Ras is mutated. As there are three isoforms, we performed the same analysis for cases when less than 50% of total cellular Ras is mutated and obtained similar results (tables S6, S7). The relative contribution of competitive inhibition on Ras activation increased when mutated Ras made up a smaller fraction of total Ras in the cell (Fig. 3B) . This further suggests competitive inhibition is likely to occur after point mutation in one of the ras genes in the cell.
To test the predicted effect of competitive inhibition of Ras GAPs on Ras activation we performed a Ras-binding domain (RBD) pulldown assay on three cancer cell lines that harbor GAP-insensitive Ras mutations (T24: H-Ras G12V ; HT1080: N-Ras Q61L ; MDA-MB-231: K-Ras G13D ) and, as controls, two cell lines in which activating Ras mutations have not been described (HeLa, HEK-293T). We found a statistically significant increase in the proportion of GTP-bound Ras WT for the cells harboring GAP-insensitive Ras point mutants (Fig. 3C) . Taken together, our combined computational and experimental work uncovered a systems-level process that our simulations predict could contribute upwards of 30% of the Ras GTP found in a cell with an activating point mutation. Our results indicate that cancers will likely display significant heterogeneity because of secondary activation of other WT Ras isoforms in the same cell.
Ideally, a therapeutic strategy to inhibit Ras signaling would have a much stronger effect on diseased cells with an oncogenic Ras mutation than on healthy cells without a Ras mutation (2) . The Ras signaling network is characterized by different properties for cancerous and noncancerous cells, and a nonlinear dynamical system can have quantitatively and/or qualitatively different behaviors for different sets of system parameters. We therefore hypothesized that a drug binding both Ras G12V and Ras WT with equal affinity could block Ras signaling in the cancerous network more than the wild-type network. To first test the ability of our model to assess possible pharmaceutical strategies, we compared the dose-dependent inhibition of Ras activation by dominant-negative Ras on a network expressing exogenous Ras G12V or Ras WT . The model showed that dominantnegative Ras S17N had a stronger effect on the wild-type network (Fig. 4A and fig. S4 ). This is consistent with experimental observations that Ras S17N inhibited Ras WT signaling more than it did oncogenic Ras signaling (21) . This observation, once considered "unexpected" (21) , is readily explained from our systemslevel model.
To search for a therapeutically beneficial strategy, we extended our model to examine three possible strategies of drug intervention: (i) a hypothetical drug A that binds and sequesters Ras GDP , (ii) a potential drug B that binds and sequesters Ras GTP , and (iii) a drug C that binds and sequesters both Ras GDP and Ras GTP equally well ( fig. S5) (22, 23) . In our simulations, drug B was no longer selective under these conditions (Fig.  4D) . Thus, the use of Ras G12V -transfected cell lines may yield false-negatives when used to screen for drugs that selectively target cancerous cells.
Oncogenic Ras has been well studied at the genetic, biochemical, and whole-animal levels. This molecular network level analysis of the Ras signaling module provided a bridge between the biochemical data at the protein level and Ras activation at the cellular level. The systems-level analysis of the wild-type Ras network and an oncogenic Ras network also identified a strategy that selectively targeted the mutant network as a result of quantitative differences between the two networks. Similar strategies might be found for other networks where mutations alter biochemical properties and result in pathological deregulation. These results highlight the promise of systems-level mathematical models to study signaling pathways altered in disease and to identify potential drug strategies. (1, 2) , allowing them to anticipate daily and annual environmental cycles and to adjust their biochemical, physiological, and behavioral processes accordingly (1). The circadian clock uses cues such as light to entrain endogenous oscillators, which in turn control rhythmic outputs of a wide range of organisms (2) . Even simple animals such as medusae (scyphozoan or hydrozoan cnidarians) have specialized lightsensing organs known as ocelli (eyes) or eyespots. These photoreceptors react to changes in light intensity and are responsible for phototaxis and other behavioral responses to light (3). However, anthozoan cnidarians (corals, sea anemones, and sea pens) lack specialized sense organs yet display photosensitive behavior (4-11). The synchronized mass spawning on the Great Barrier Reef (GBR) in Australia is a spectacular example of the photosensitive responses exhibited by these organisms (7) (8) (9) . Over several nights after the full moon in late spring each year, hundreds of coral species spawn en masse, with the final trigger being changes in the lunar irradiance intensity (8, 11) .
The specific cellular mechanisms involved in light detection by reef-building corals (Anthozoa, Cnidaria) have remained elusive. Biophysical data (4) show that corals are highly sensitive to blue light, which is also known to entrain the circadian clocks of insects and mammals (12) via cryptochromes (CRYs), which are DNA photolyase-like photoreceptor proteins. The roles of cryptochromes differ subtly between mammals and insects; the proteins function as circadian oscillator components in Mus but as photoreceptors for clock entrainment in Drosophila (13, 14) . To date, CRYs have been identified only in higher animals such as vertebrates and insects, although related (and divergent) proteins have been reported in plants and eubacteria (12) .
We used degenerate primers based on sequences conserved between Mus, Drosophila, Xenopus, and Danio to clone two cry genes from the coral Acropora millepora (15) . The proteins encoded by the genes cry1 and cry2 each contain an N-terminal photolyase-related region (PHR) bearing two chromophorebinding domains and C-terminal domains extending 54 (CRY1) or 27 (CRY2) amino acids in length. cry1 and cry2 were also identified in expressed sequence tag (EST) data sets generated from A. millepora larvae (16), as were two additional genes known here as cry3 (15) and cry-dash. Because the cDNA library was constructed from aposymbiotic larvae, these cry genes are likely to be from coral rather than from associated symbiotic algae or marine microbes.
Phylogenetic analyses (Fig. 1 ) emphasize the similarity of coral CRYs and their vertebrate counterparts. Coral CRY1 belongs to the mammalian-type (m-type) CRY group. Both CRY1 and CRY2 are only distantly related to the Drosophila-type CRYs. CRY2 more closely resembles the Danio photoreceptor candidate CRY4-type (17) and is basal to the clade comprising both the m-type CRYs and the (6-4) photolyases. Coral CRY-DASH is a typical CRY-DASH protein (18) and is basal in the animal CRY-DASH clade. This analysis suggests that coral CRYs may represent ancestral members of the protein family in the animal kingdom, potentially providing insights into the origins of light perception in animals.
On the GBR, we investigated (15) whether the expression of cry1 and cry2 in corals is rhythmic only under light/dark (LD) cycles as in Drosophila (13) or driven by an endogenous
